Study of Human Immunodeficiency Virus Resistance to 2'-3'-Dideoxyinosine and Zidovudine in Sequential Isolates from Pediatric Patients on Long-Term Therapy
D Dimitrov(The University of Texas MD Anderson Cancer Center), William T. Shearer(Baylor College of Medicine), F. Blaine Hollinger, Carol J. Baker(Baylor College of Medicine), James W. Bremer(Rush University Medical Center), Mark W. Kline(Tulane University), M. Doyle
Cited by 13
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Viral Load and Disease Progression in Infants Infected with Human Immunodeficiency Virus Type 1
|New England Journal of Medicine|1997|551
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses
|Clinical Infectious Diseases|2017|453
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The Primary Immune Deficiency Treatment Consortium experience
|Journal of Allergy and Clinical Immunology|2013|343